MAIRE’s Nextchem wins TMA licensing, process design and technical services contract in China with NX CONSER C5+

Key highlights
  • Nextchem/Conser awarded licensing, Process Design Package and technical services for a Trimellitic Anhydride (TMA) plant in China using NX CONSER C5+
  • Technology enables continuous TMA production with reduced power, steam and water consumption
  • TMA will be used for PVC plasticizers, coatings and polyester resins
  • Project staged in two phases with option to supply proprietary equipment later

Project award

Conser, a Nextchem subsidiary, was awarded licensing, a Process Design Package and technical services by a Chinese client to build a Trimellitic Anhydride (TMA) plant in China.

Technology and efficiency

The plant will use Nextchem’s proprietary NX CONSER C5+ TMA technology for continuous production; the design uses innovative construction materials and targets reduced power, steam and water consumption while supporting safety and reliability.

Applications

TMA is a key intermediate for high-performance PVC plasticizers used in electrical, automotive and medical applications, and is also used in coating formulations and polyester resins.

Project execution

The project is structured in two phases to enable progressive implementation and the contract allows for optional supply of proprietary equipment at a later stage.

Source: Maire

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

28 April 2026
MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China

Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.

30 July 2026
MAIRE: H1 2026 results — €3.7bn revenues, strong order intake and M&A in Nextchem

Revenues +6.9% to €3.68bn; EBITDA +14.7% to €266.2m; H1 order intake €7.2bn, backlog €16.3bn; Nextchem buys Ballestra and 70% of ETEK.

29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed

Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share